We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE ... The Centers for Medicare & Medicaid Services reported that healthcare spending in the US reached $4.9 trillion ...

Novo Nordisk's stock closed about 5% higher on ... weight loss drugs such as Wegovy are not currently covered by Medicare and other insurance. Don't expect a 20% S&P 500 three-peat this year ...

The Centers for Medicare & Medicaid Services reported ... beating its benchmark by 150 percentage points (see more details here). Novo Nordisk A/S (NYSE:NVO) is a global healthcare company ...